Phase I Alimta Combination With BMS-275183 (Oral Taxane)
Phase I Alimta Combination With BMS-275183 (Oral Taxane)
A phase I-II dose ranging study of BMS-275183 (oral taxane) in combination with pemetrexed (Alimta) in patients with recurrent Non-Small Cell Lung Cancer (NSCLC). The safety and efficacy of this combination will be studied.
Inclusion Criteria:
Exclusion Criteria: